Hospital staff shortages spurred drop in TAVR procedures in Q3, surgeon survey shows

Hospital staff shortages and supply-chain disruption limited procedure volume growth in the third quarter, suggesting that the challenges will again affect medtech financial results.
That is the conclusion of a Stifel survey of 150 U.S. surgeons working in interventional cardiology, general surgery and orthopedics. The interventional cardiologists gave the most pessimistic responses, reporting that they performed fewer transcatheter aortic valve replacement (TAVR) procedures than in the second quarter.